GC6101A

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC6101A, covering 2015-07-03 to 2015-07-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis [Phase 2]